FullHope Biomedical Co (ROCO:7773) Operating Margin %: -86.98% (As of Dec. 2025)


ROCO:7773 FullHope Biomedical Co Ltd ROCO:7773
14 GF Score
Price NT$27.65
! 1 Warning Sign
View Full Analysis

What is FullHope Biomedical Co Operating Margin %?

FullHope Biomedical Co ROCO:7773 14 Operating Margin % is -86.98% as of Dec. 2025. GuruFocus rates ROCO:7773 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review. Among 939 Biotechnology companies, FullHope Biomedical Co ranks worse than 52.93% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. FullHope Biomedical Co's Operating Income for the six months ended in Dec. 2025 was NT$-22.22 Mil. FullHope Biomedical Co's Revenue for the six months ended in Dec. 2025 was NT$25.55 Mil. Therefore, FullHope Biomedical Co's Operating Margin % for the quarter that ended in Dec. 2025 was -86.98%.

The historical rank and industry rank for FullHope Biomedical Co's Operating Margin % or its related term are showing as below:

ROCO:7773' s Operating Margin % Range Over the Past 10 Years
Min: -313.95   Med: -242.92   Max: -109.67
Current: -109.67


ROCO:7773's Operating Margin % is ranked worse than
52.93% of 939 companies
in the Biotechnology industry
Industry Median: -86.77 vs ROCO:7773: -109.67

FullHope Biomedical Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

FullHope Biomedical Co's Operating Income for the six months ended in Dec. 2025 was NT$-22.22 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-47.82 Mil.


FullHope Biomedical Co  (ROCO:7773) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


FullHope Biomedical Co Operating Margin % Related Terms


FullHope Biomedical Co Operating Margin % Historical Data

* Premium members only.

The historical data trend for FullHope Biomedical Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FullHope Biomedical Co Operating Margin % Chart

FullHope Biomedical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
0.00 -308.32 -177.51 -313.95 -109.67

FullHope Biomedical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial -277.04 -362.85 -284.64 -141.76 -86.98

ROCO:7773 vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, FullHope Biomedical Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FullHope Biomedical Co Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FullHope Biomedical Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where FullHope Biomedical Co's Operating Margin % falls into.


ROCO:7773
14GF Score
FullHope Biomedical Co Ltd ROCO:7773
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FullHope Biomedical Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

FullHope Biomedical Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-47.815 / 43.6
=-109.67 %

FullHope Biomedical Co's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-22.22 / 25.545
=-86.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -86.98% mean?
FullHope Biomedical Co (ROCO:7773) has a Operating Margin % of -86.98% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on FullHope Biomedical Co and its competitors. According to the industry distribution chart, FullHope Biomedical Co ranks #497 out of 939 companies in the Biotechnology industry, placing it in the top 52.9%.
Is FullHope Biomedical Co's Operating Margin % too high?
FullHope Biomedical Co's current Operating Margin % is -86.98%. Based on the distribution chart, FullHope Biomedical Co ranks #497 out of 939 companies in the Biotechnology industry, which is below the industry midpoint. Overall, FullHope Biomedical Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does FullHope Biomedical Co's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, FullHope Biomedical Co ranks #497 out of 939 companies for Operating Margin %. This places FullHope Biomedical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on FullHope Biomedical Co and its competitors. FullHope Biomedical Co's current Operating Margin % is -86.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FullHope Biomedical Co stock overvalued right now?
FullHope Biomedical Co (ROCO:7773) has a current Operating Margin % of -86.98%. The current Operating Margin % is -86.98%. FullHope Biomedical Co's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For FullHope Biomedical Co (ROCO:7773), the current Operating Margin % is -86.98% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FullHope Biomedical Co Business Description

Address Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.
14GF Score

Get the complete analysis for ROCO:7773

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$27.65
Price